• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Lakesha Farmer of Cencora Suggests Strategies for Ensuring Patient Access to Biosimilar Cost Savings | Asembia 2024


Managed Healthcare Executive spoke with Lakesha Farmer, Pharm.D., MBA, senior director, ION Oncology Practice Network, Cencora about how cost savings from biosimilars can be effectively passed on to patients.

Farmer shared that biosimilars were introduced to create competition and lower costs across the healthcare system.

She explained that while patients have indirectly benefited from cost savings through providers reallocating funds, there's room for improvement in providing direct savings.

She suggested implementing policies, similar to those seen with Medicare Part D, to cap out-of-pocket costs for patients.

Farmer also stressed the importance of patient-centered care and education when considering biosimilar usage to minimize disruptions and ensure optimal care.

In addition, she highlighted the need to focus on both affordability and quality of care for patients.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.